Stock screenerAll disclosures →
EDGAR →
ALNY
Conviction 0HealthcareScan · Mon, Aug 10, 2026ALNY$216.91-1.04%
ResistanceSupportVol 14Insider sellCongress buyCongress sell5
Vol MA14 2.61M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price216.91
Change-1.04%
Gap+0.53%
Rel volume0.62×
Avg volume2.2M
Avg $ vol517.27M
SMA 20252.36
SMA 50278.68
SMA 200341.55
Price vs 50-22.17%
Price vs 200-36.49%
MA stackbearish
50/200 cross—
Supertrenddown · 260.00
RSI (14)34
MACD hist-3.75
MACD crossbear · 7d
Stoch %K / %D21 / 21
ADX (14)25
+DI / −DI23 / 37
RSI divergence—
MACD divergence—
ATR %+7.00%
ADR %4.63%
52w high491.22
52w low205.48
From 52w high-55.84%
Above 52w low+5.56%
New 52w highNo
SqueezeOff
Bollinger width47.91%
%B0.21
Donchian pos20.58%
Donchian high290.60
Donchian low197.81
AVWAP (52w high)334.32
vs AVWAP high-35.12%
AVWAP (52w low)214.46
vs AVWAP low+1.14%
OBV trendFlat
Chaikin MF (20)0.02
Today vs 20d0.62×
Avg vol (14d)2.61M
Avg vol (20d)2.2M
Avg $ vol (20d)517.27M
Market cap29.02B
RS 3m (vs SPY)-31.62%
RS 6m (vs SPY)-47.94%
RS line new highNo
Trend template0/8
Technical rank7.4
1 week-1.55%
1 month-27.40%
3 months-26.48%
6 months-33.90%
1 year-50.15%
YTD-45.80%
P/E92.51
P/B21.43
P/S7.82
P/FCF62.37
EPS2.33
Div yield—
ROE23.17%
ROA5.64%
Debt/Eq0.50
Current3.05
EV/EBITDA54.36
Gross margin—
Net margin8.45%
Rev growth65.19%
EPS growth212.79%
Price target372.67
Target upside71.81%
Analyst ratingBuy
Institutional111.32%
Ent. value27.99B
Revenue1.29B
Net income164.49M
Gross profit—
Free cash flow465.38M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out133.51M
Employees2.5K
ListedFri, May 28, 2004
Free float132.42M
Float %99.9%
Short interest5.77M
Days to cover3.2d
Short volume36.2%
Squeeze score25 / 100
Next earnings—
EPS forecast—
Last EPS vs est$1.21 vs $1.44
Last surprise-16.0% miss
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank7.4 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance341.73
Support230.01
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ALNY · 1 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Jefferson Shreve house · R · IN · traded 2025-05-12 | Sell | $15K–$50K | 2025-05-12 | 2025-06-22 |
Insider activity
SEC Form 4 transactions in ALNY · 2 buys · 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
PYOTT DAVID E I Director · Common Stock · 2026-06-01 | Sell | 495 | $149K | 2026-06-01 | 2026-06-03 |
PYOTT DAVID E I Director · Common Stock · 2026-06-01 | Other | — | — | 2026-06-01 | 2026-06-03 |
PYOTT DAVID E I Director · Common Stock · 2026-06-01 | Sell | 17 | $5K | 2026-06-01 | 2026-06-03 |
PYOTT DAVID E I Director · Common Stock · 2026-06-01 | Sell | 1.18K | $351K | 2026-06-01 | 2026-06-03 |
PYOTT DAVID E I Director · Common Stock · 2026-06-01 | Exercise | 3.83K | $0 | 2026-06-01 | 2026-06-03 |
PYOTT DAVID E I Director · Stock Option (Right to Buy) · 2026-06-01 | Exercise | 3.83K | $0 | 2026-06-01 | 2026-06-03 |
PYOTT DAVID E I Director · Common Stock · 2026-06-01 | Sell | 1.22K | $366K | 2026-06-01 | 2026-06-03 |
Cravatt Benjamin Director · Stock Option (Right to Buy) · 2026-06-01 | Grant | 4.39K | $0 | 2026-06-01 | 2026-06-03 |
PYOTT DAVID E I Director · Common Stock · 2026-06-01 | Sell | 921 | $274K | 2026-06-01 | 2026-06-03 |
Sigal Charles Elliott Director · Common Stock · 2026-05-20 | Other | — | — | 2026-05-20 | 2026-05-22 |
SEC filings
EDGAR filings in ALNY · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.